Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis

24Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tissue-type plasminogen activators (tPA) and urokinase-type plasminogen activators (uPA) are involved in liver repair. We examined the potential immunomodulatory actions of uPA, tPA and uPA-receptor (uPAR) in carbon-tetrachloride-induced hepatic fibrosis in wild-type (WT), tPA -/-, uPA-/- and uPAR-/- mice. Carbon-tetrachloride treatment increased fibrosis in four groups but significantly less in three knock-out models. Serum cytokines and intrahepatic T cells elevated significantly following fibrosis process in WT animals but not in the knock-out groups. In culture, uPA increased lymphocyte proliferation significantly in WT and uPA-/- but not uPAR-/- animals. Following uPA exposure in vivo, there was CD8 predominance. To isolate uPA's effect on lymphocytes, WT mice were irradiated sublethally and then reconstituted with WT or uPA-/- lymphocytes. In these animals fibrosis was decreased and T cells were reduced in the uPA-/- recipients. Based on these data we postulate that plasminogen activators affect fibrosis in part by liver-specific activation of CD8 subsets that govern the fibrogenic activity of hepatic stellate cells. © 2008 The Author(s).

Cite

CITATION STYLE

APA

Higazi, A. A., El-Haj, M., Melhem, A., Horani, A., Pappo, O., Alvarez, C. E., … Safadi, R. (2008). Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis. Clinical and Experimental Immunology, 152(1), 163–173. https://doi.org/10.1111/j.1365-2249.2008.03606.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free